1.
Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
by Cuchel, Marina, Dr
The Lancet (British edition), 2013, Vol.381 (9860), p.40-46
2.
Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study
by Talmud, Philippa J, Prof
The Lancet (British edition), 2013, Vol.381 (9874), p.1293-1301
3.
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double...
by Raal, Frederick J, Prof
The Lancet (British edition), 2010, Vol.375 (9719), p.998-1006
4.
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
by Voight, Benjamin F, PhD
The Lancet (British edition), 2012-08-11, Vol.380 (9841), p.572-580
5.
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable st...
by Stein, Evan A, Prof, Dr
The Lancet (British edition), 2012, Vol.380 (9836), p.29-36
6.
National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years an...
by Farzadfar, Farshad, MD
The Lancet (British edition), 2011, Vol.377 (9765), p.578-586
7.
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LA...
by Giugliano, Robert P, Dr
The Lancet (British edition), 2012, Vol.380 (9858), p.2007-2017
8.
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a rando...
by Koren, Michael J, Dr
The Lancet (British edition), 2012, Vol.380 (9858), p.1995-2006
9.
Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies
by Nherera, L
Heart (British Cardiac Society), 2011-07, Vol.97 (14), p.1175-1181
10.
Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia
by Akdim, Fatima, MD
The American journal of cardiology, 2010, Vol.105 (10), p.1413-1419
11.
Postprandial Hyperglycemia/Hyperlipidemia (Postprandial Dysmetabolism) Is a Cardiovascular Risk Factor
by O’Keefe, James H., MD
The American journal of cardiology, 2007, Vol.100 (5), p.899-904
12.
Obesity and Hypertriglyceridemia Produce Cognitive Impairment
by Farr, Susan A
Endocrinology (Philadelphia), 2008-05, Vol.149 (5), p.2628-2636
13.
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial
by Ridker, Paul M, Prof
The Lancet (British edition), 2010, Vol.376 (9738), p.333-339
14.
Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk
by Humphries, S E
Journal of medical genetics, 2006-12, Vol.43 (12), p.943-949
15.
Comparison of Genetic Versus Clinical Diagnosis in Familial Hypercholesterolemia
by Civeira, Fernando, MD, PhD
The American journal of cardiology, 2008, Vol.102 (9), p.1187-1193.e1
16.
Hepatic Suppression of Foxo1 and Foxo3 Causes Hypoglycemia and Hyperlipidemia in Mice
by Zhang, Kebin
Endocrinology (Philadelphia), 2012-02, Vol.153 (2), p.631-646
17.
Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular...
by Robinson, Jennifer G., MD, MPH
The American journal of cardiology, 2012, Vol.110 (10), p.1468-1476
18.
Longitudinal Evaluation and Assessment of Cardiovascular Disease in Patients With Homozygous Familial Hypercholesterolemia
by Kolansky, Daniel M., MD
The American journal of cardiology, 2008, Vol.102 (11), p.1438-1443
19.
Use of targeted exome sequencing as a diagnostic tool for Familial Hypercholesterolaemia
by Futema, Marta
Journal of medical genetics, 2012-10, Vol.49 (10), p.644-649
20.
Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-con...
by Davidson, Michael H., MD
Clinical therapeutics, 2007, Vol.29 (7), p.1354-1367
